S100A9 and breast carcinoma: CD55 was selected as part of the overlap between differentially expressed genes in patients with high levels of S100A9, scored in a published cohort of breast cancer brain metastases59, and the in vitro and ex vivo radioresistant surrogates (Fig. 4c, Supplementary Fig. 2d and Supplementary Table 11).